Howard Grossman
Internal Medicine · Phoenix, AZNPI 1710951694
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $105,448 of the $131,288 with a category attached, or 80.3%. 19 manufacturers reported payments, led by Gilead at 52.7% of the total. Reporting peaked in 2022 at $38,399 and has fallen 94.2% since, to $2,215 in 2025. Among internal medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 484 payments — averaging $271.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$69K
- Viiv Healthcare Company$59K
- Theratechnologies Inc.$2K
- Merck$417
- Johnson & Johnson$350
- Janssen Products, LP$251
- plus $630 from 13 others
What the payments were for
- Consulting fees$8,3006%
- Speaking & faculty fees$105,44880%
- Travel & lodging$7,3736%
- Food & beverage$10,0128%
- Education$1540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 238 | $69,212 |
| Viiv Healthcare Company | 163 | $58,849 |
| Theratechnologies Inc. | 5 | $1,579 |
| Merck | 16 | $417 |
| Johnson & Johnson | 26 | $350 |
| Janssen Products, LP | 3 | $251 |
| Napo Pharmaceuticals Inc | 12 | $228 |
| Janssen Scientific Affairs, LLC | 4 | $79 |
| EMD Serono, Inc. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| AbbVie(2 entities) | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| VBI Vaccine (delaware) Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $27 |
| Exact Sciences | 1 | $21 |
| Baxter Healthcare | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Mylan Institutional Inc. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$131,288 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $20,855 |
| LinzessLinaclotide | 12 | $6,445 |
| Duloxetine Hcl | 24 | $897 |
| Atorvastatin Calcium | 89 | $890 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $695 |
| Gabapentin | 31 | $679 |
| Amlodipine Besylate | 86 | $600 |
| Mycophenolate Mofetil | 13 | $584 |
| Losartan Potassium | 71 | $579 |
| Tamsulosin Hcl | 35 | $516 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 31 | $473 |
| Omeprazole | 25 | $463 |
| Triamcinolone Acetonide | 15 | $394 |
| Levothyroxine Sodium | 49 | $389 |
| Rosuvastatin Calcium | 33 | $368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $41 | $6,44512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,212 internal medicine providers in Arizona.
Other internal medicine in Phoenix
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Kelly KrohnPhoenix$262K
- Paul StanderPhoenix$222K
- Nafis Shamsid-DeenPhoenix$115K
- Shishir MurarkaPhoenix$79K
- Mark WongPhoenix$71K
- Geoffrey OrmePhoenix$27K
- Roberto RuizPhoenix$25K
- Louise TaberPhoenix$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.